LymPro's 94% sensitivity is sufficient for pharmas to start signing up now. I think however they are trying to improve the specificity numbers with this new biomarker they've discovered and intend to release the improved multivariate numbers when they seek CLIA authorization.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links